Admedus" CardioCell biomaterial scaffold technology validated by independent peer-reviewed study - Proactive Investors Australia

Admedus" CardioCell biomaterial scaffold technology validated by independent peer-reviewed study  Proactive Investors Australia

Admedus Ltd (ASX:AHZ) has had its CardioCel transcatheter aortic valve replacement (TAVR) devices validated through the publication of an independent study ...



Comments

Popular posts from this blog

Inside Ontario’s ‘scary’ child-welfare system where kids are ‘commodities’ - Global News

Woodstock, Ont. OB-GYN used improperly sterilized medical equipment, health unit says - Global News

Глушители. Приборы бесшумной стрельбы